Apr 12 |
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
|
Mar 13 |
Kazia announces presentation of new data at AACR Annual Meeting
|
Feb 21 |
Kazia concludes Phase 1 study for paxalisib early due to promising data
|
Feb 21 |
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
|
Jan 18 |
KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
|
Dec 15 |
Kazia Therapeutics files to sell 591,697 ADSs for holders
|
Dec 5 |
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
|
Dec 1 |
Kazia Therapeutics falls after announcing $2M direct offering
|
Dec 1 |
Kazia Therapeutics Announces $2 Million Registered Direct Offering
|
Nov 29 |
Kazia stock jumps after proposed license deal for paxalisib outside oncology
|